Cargando…
Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block
Pembrolizumab is a monoclonal antibody directed towards programmed cell death protein 1 (PD-1) and is an antineoplastic drug which has a growing variety of oncologic uses. Pembrolizumab is commonly associated with immune-related adverse events (IRAEs) but is infrequently noted to cause cardiotoxicit...
Autores principales: | Khan, Alisha, Riaz, Sana, Carhart, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007942/ https://www.ncbi.nlm.nih.gov/pubmed/32047674 http://dx.doi.org/10.1155/2020/8428210 |
Ejemplares similares
-
Pseudo atrioventricular block most likely caused by junctional extrasystoles mimicking Mobitz II second degree atrioventricular block: A case report
por: Hollanda, Lucas, et al.
Publicado: (2020) -
A Mobitz type II atrioventricular block in multicentric ischemic stroke
por: Kalafat, Utku Murat, et al.
Publicado: (2016) -
Mobitz type II, 2:1 atrioventricular block mimicking as a convulsive seizure
por: Kaya, Çağlar, et al.
Publicado: (2019) -
Case of reversible Mobitz type II atrioventricular block after the use of injectable antipsychotics
por: Naono, Hisao, et al.
Publicado: (2022) -
Mobitz Type II Atrioventricular Block Followed by Remifentanil in a Patient with Severe Aortic Stenosis
por: Taghavi Gilani, Mehryar, et al.
Publicado: (2013)